• Skip to primary navigation
  • Skip to main content
IMMUNOLOGY2023™

IMMUNOLOGY2023™

May 11–15, 2023 | Washington, DC

  • Policy
    • COVID Policy
    • Press Credentials and Policy
  • Program
    • At a Glance
    • By Day
      • Thursday, May 11
      • Friday, May 12
      • Saturday, May 13
      • Sunday, May 14
      • Monday, May 15
    • President’s Program
    • Distinguished Lectures
    • Special Session
    • Major Symposia
    • Committee-Sponsored Sessions
    • Guest Sessions
    • Block Symposia
    • Poster Sessions
    • Award Presentations & Lectures
    • Career Development Opportunities
    • Exhibitor Workshops
    • Social Events
    • Meeting Guide (PDF)
  • For Speakers
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
    • Program Acknowledgements
    • Speaker Disclosures
  • Abstracts
    • View Abstracts Here
    • Poster Presentation Guidelines
    • Podium Presentation Guidelines
    • Submission Guidelines
    • Topic Categories
    • Editing or Withdrawing
    • Publication and Citation
    • Notification of Programming
  • Register
  • Awards
  • Careers
    • Jobs Board
    • For Employers
    • For Job Seekers
  • Hotels
  • Exhibitors
    • Exhibitor Workshops
    • Exhibitors – Start Here
    • Sponsorship
  • Sponsors
  • FAQ
  • Show Search
Hide Search
 Thursday, May 11, 2023     2:00 PM – 4:00 PM ET     Room 207B

Block Symposium

Myeloid Cells in Cancer Hosts I

Chairs

  • Melanie R. Rutkowski, Univ. of Virginia
  • Tracy McGaha, Univ. Hlth. Network

Speakers

  • Mitchell Thomas McGinty, Univ. of Virginia, Absence of Toll-like receptor 5 confers survival in mice bearing ovarian tumors treated with anti-PD-L1
  • Anthony Michael Cannon, Indiana Univ. Sch. of Med., IL-9 responsive macrophages utilize Arginase 1 to enhance lung tumor growth
  • Devanshi A. Nayak, Univ. of Pittsburgh Sch. of Med., Elucidating the role of heat shock protein receptor CD91 on antigen presenting cells during cancer immunosurveillance
  • Sara Lamorte, Univ. Hlth. Network, Canada, Medullary sinus macrophages limit cancer therapy efficacy by an efferocytosis-induced IL-33/ST2 axis in the tumor-draining lymph node
  • Olivia J. Cheng, Univ. of Utah Sch. of Med., MAIT cell-mediated inhibition of colorectal tumor growth is associated with increase in IL-5 and accumulation of eosinophils in the tumor microenvironment
  • Hyun-Jin Kim, Korea Adv. Inst. of Sci. and Technol., South Korea, Monocyte-derived CD169+ macrophages advance the antitumor immunity against glioblastoma multiforme

All IMMUNOLOGY2023™ attendees are required to comply with the AAI COVID-19 policy.

IMMUNOLOGY2023™
May 11—15, 2023
Walter E. Washington Convention Center
Washington, DC

AAI Courses
JOIN AAI NOW
Publish in The Journal of Immunology
Publish in ImmunoHorizons
Facebook
Twitter
Instagram
TikTok
LinkedIn

IMMUNOLOGY2023™

Copyright © 2025 The American Association of Immunologists, Inc. All rights reserved.

  • FAQ
  • Code of Conduct
  • COVID Policy
  • Press Policy
  • Privacy Policy

Jobs Board submissions for IMMMUNOLOGY2023™ are closed. Please post your jobs on the physical jobs board onsite in the convention center.